| Aprovel 150 mg film-coated tablets EU/1/97/046/021-025 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Aprovel 150 mg tablets EU/1/97/046/004-006 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Aprovel 300 mg film-coated tablets EU/1/97/046/026-030 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Aprovel 300 mg tablets EU/1/97/046/007-009 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Aprovel 75 mg film-coated tablets EU/1/97/046/016-020 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Aprovel 75 mg tablets EU/1/97/046/001-003 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| AUBAGIO 14 mg film-coated tablets EU/1/13/838/001-005 |
Teriflunomide |
Sanofi Winthrop Industrie |
— |
| AUBAGIO 7 mg film-coated tablets EU/1/13/838/006 |
Teriflunomide |
Sanofi Winthrop Industrie |
— |
| AVAXIM, suspension for injection in a pre-filled syringe Hepatitis A vaccine (inactivated, adsorbed) PA23458/003/001 |
Hepatitis a virus |
Sanofi Winthrop Industrie |
Marketed |
| Beyfortus 100 mg solution for injection in pre-filled syringe EU/1/22/1689/004-006 |
Nirsevimab |
Sanofi Winthrop Industrie |
— |
| Beyfortus 50 mg solution for injection in pre-filled syringe EU/1/22/1689/001-003 |
Nirsevimab |
Sanofi Winthrop Industrie |
— |
| CoAprovel 150 mg/12.5 mg film-coated tablets EU/1/98/086/011-015 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| CoAprovel 150 mg/12.5 mg tablets EU/1/98/086/001-003 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| CoAprovel 300 mg/12.5 mg film-coated tablets EU/1/98/086/016-020 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| CoAprovel 300 mg/12.5 mg tablets EU/1/98/086/004-006 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| DuoPlavin 75 mg/100 mg film-coated tablets EU/1/10/619/008-014 |
Acetylsalicylic acid, Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| DuoPlavin 75 mg/75 mg film-coated tablets EU/1/10/619/01-07 |
Acetylsalicylic acid, Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| Dupixent EU/1/17/1229/021-022 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Dupixent 200 mg solution for injection in pre-filled pen EU/1/17/1229/023-025 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Dupixent 200 mg solution for injection in pre-filled syringe EU/1/17/1229/009-0016 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Dupixent 300 mg solution for injection in pre-filled pen EU/1/17/1229/026-028 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Dupixent 300 mg solution for injection in pre-filled syringe EU/1/17/1229/001-008 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Efluelda suspension for injection in pre-filled syringe Trivalent influenza vaccine (split virion, inactivated), 60 micrograms HA/strain PA23458/001/001 |
Influenza Inactivated Split Virus Strain A (H1N1), Influenza Inactivated Split Virus Strain A (H3N2), Influenza Inactivated Split Virus Strain B |
Sanofi Winthrop Industrie |
Not marketed |
| Efluelda Tetra, suspension for injection in pre-filled syringe PA23458/012/001 |
Influenza Inactivated Split Virus Strain B, Influenza Inactivated Split Virus Strain A (H3N2), Influenza Inactivated Split Virus Strain B, Influenza Inactivated Split Virus Strain A (H1N1) |
Sanofi Winthrop Industrie |
Not marketed |
| Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion EU/1/00/170/001-002 |
Rasburicase |
Sanofi Winthrop Industrie |
— |
| Hexacima suspension for injection EU/1/13/828/001-007 |
Haemophilus influenzae type b capsular polysaccharide, Pertussis toxoid, (polyribosylribitol phosphate) conjugated to tetanous protein, Filamentous haemagglutinin, Type 1 (mahoney) |
Sanofi Winthrop Industrie |
— |
| Hexyon suspension for injection EU/1/13/829/001-007 |
(polyribosylribitol phosphate) conjugated to tetanous protein, Type 1 (mahoney), Haemophilus influenzae type b polysaccharide, Diphtheria toxoid, Type 2 (mef-1) |
Sanofi Winthrop Industrie |
— |
| Insulin aspart Sanofi EU/1/20/1447/001-005 |
Insulin aspart |
Sanofi Winthrop Industrie |
— |
| Insulin aspart Sanofi EU/1/20/1447/001-007 |
Insulin aspart |
Sanofi Winthrop Industrie |
— |
| Insulin lispro Sanofi 100 units/ml solution for injection EU/1/17/1203/001-008 |
Insulin lispro |
Sanofi Winthrop Industrie |
— |
| Iscover 300 mg film-coated tablets EU/1/98/070/8-10 |
Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| Iscover 75 mg film-coated tablets EU/1/98/070/001 |
Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| JEVTANA 60 mg concentrate and solvent for solution for infusion EU/1/11/676/001 |
Cabazitaxel |
Sanofi Winthrop Industrie |
— |
| Karvea 150 mg film-coated tablets EU/1/97/049/021-025 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 150 mg tablets EU/1/97/049/004-006 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 300 mg film-coated tablets EU/1/97/049/026-030 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 300 mg tablets EU/1/97/049/007-009 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 75 mg film-coated tablets EU/1/97/049/016-020 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 75 mg tablets EU/1/97/049/001-003 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvezide 150 mg/12.5 mg film-coated tablets EU/1/98/085/011-015 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Karvezide 150 mg/12.5 mg tablets EU/1/98/085/001-003 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Karvezide 300 mg/12.5 mg film-coated tablets EU/1/98/085/016-020 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Karvezide 300 mg/12.5 mg tablets. EU/1/98/085/004-006 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Karvezide 300 mg/25 mg film-coated tablets EU/1/98/085/023-028 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Kevzara 150 mg solution for injection in pre-filled syringe EU/1/17/1196/001-002 |
Sarilumab |
Sanofi Winthrop Industrie |
— |
| Kevzara 175 mg/ml solution for injection EU/1/17/1196/013 |
Sarilumab |
Sanofi Winthrop Industrie |
— |
| Kevzara 200 mg solution for injection in pre-filled syringe EU/1/17/1196/003-008 |
Sarilumab |
Sanofi Winthrop Industrie |
— |
| MenQuadfi solution for injection EU/1/20/1483/001-002 |
Neisseria Meningitidis Group A Polysaccharide, Neisseria Meningitis Group W135 Polysaccharide, N. Meningitidis Group Y Polysaccharide, Tetanus toxoid, N. Meningitidis Group C Polysaccharide |
Sanofi Winthrop Industrie |
— |
| MULTAQ 400 mg film-coated tablets EU/1/09/591/1-4 |
Dronedarone hydrochloride |
Sanofi Winthrop Industrie |
— |
| Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) EU/1/21/1618/001 |
SARS-CoV-2 spike protein recombinant |
Sanofi Winthrop Industrie |
— |